U S PHYSICAL THERAPY INC /NV Operating Lease Cost
U S PHYSICAL THERAPY INC /NV (USPH) reported Operating Lease Cost of $13.15 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-08-07
- U S PHYSICAL THERAPY INC /NV operating lease, cost for the quarter ending 2026-06-30 was $13.15M, a 9.05% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV operating lease, cost for the quarter ending 2026-03-31 was $13.04M, a 11.29% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV operating lease, cost for the quarter ending 2025-12-31 was $12.91M, a 15.52% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV operating lease, cost for the quarter ending 2025-09-30 was $12.35M, a 19.19% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV operating lease, cost for fiscal 2025 was $49.03M, a 17.44% increase from fiscal 2024.
- U S PHYSICAL THERAPY INC /NV operating lease, cost for fiscal 2024 was $41.75M, a 8.28% increase from fiscal 2023.
- U S PHYSICAL THERAPY INC /NV operating lease, cost for fiscal 2023 was $38.56M, a 9.69% increase from fiscal 2022.
- U S PHYSICAL THERAPY INC /NV operating lease, cost for fiscal 2022 was $35.15M, a 9.78% increase from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 3 month as first filed | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 9 month as first filed | Operating Lease, Cost 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13.15M 10-Q · filed 2026-08-07 | $26.19M 10-Q · filed 2026-08-07 | $39.09M derived: sum of 3 quarters · filed 2026-08-07 | $51.45M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2026-03-31 | $13.04M 10-Q · filed 2026-05-08 | $25.95M derived: sum of 2 quarters · filed 2026-05-08 | $38.30M derived: sum of 3 quarters · filed 2026-05-08 | $50.35M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-12-31 | $12.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $25.26M derived: sum of 2 quarters · filed 2026-02-27 | $37.31M derived: sum of 3 quarters · filed 2026-08-07 | $49.03M 10-K · filed 2026-02-27 | ||
| 2025-09-30 | $12.35M 10-Q · filed 2025-11-07 | $24.41M derived: sum of 2 quarters · filed 2026-08-07 | $36.12M 10-Q · filed 2025-11-07 | $47.30M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-06-30 | $12.06M 10-Q · filed 2026-08-07 | $23.77M 10-Q · filed 2026-08-07 | $34.95M derived: sum of 3 quarters · filed 2026-08-07 | $45.31M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-03-31 | $11.72M 10-Q · filed 2026-05-08 | $22.89M derived: sum of 2 quarters · filed 2026-05-08 | $33.25M derived: sum of 3 quarters · filed 2026-05-08 | $43.51M derived: sum of 4 quarters · filed 2026-05-08 | ||
| 2024-12-31 | $11.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $21.54M derived: sum of 2 quarters · filed 2026-02-27 | $31.80M derived: sum of 3 quarters · filed 2026-02-27 | $41.75M 10-K · filed 2026-02-27 | ||
| 2024-09-30 | $10.36M 10-Q · filed 2025-11-07 | $20.63M derived: sum of 2 quarters · filed 2025-11-07 | $30.58M 10-Q · filed 2025-11-07 | $40.64M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2024-06-30 | $10.26M 10-Q · filed 2025-08-08 | $20.22M 10-Q · filed 2025-08-08 | $30.27M derived: sum of 3 quarters · filed 2026-02-27 | $40.00M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2024-03-31 | $9.95M 10-Q · filed 2025-05-09 | $20.01M derived: sum of 2 quarters · filed 2026-02-27 | $29.74M derived: sum of 3 quarters · filed 2026-02-27 | $39.15M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2023-12-31 | $10.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $19.78M derived: sum of 2 quarters · filed 2026-02-27 | $29.19M derived: sum of 3 quarters · filed 2026-02-27 | $38.56M 10-K · filed 2026-02-27 | ||
| 2023-09-30 | $9.72M 10-Q · filed 2024-11-08 | $19.14M derived: sum of 2 quarters · filed 2024-11-08 | $28.50M 10-Q · filed 2024-11-08 | $37.68M derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2023-06-30 | $9.41M 10-Q · filed 2024-08-14 | $18.77M 10-Q · filed 2024-08-14 | $27.95M derived: sum of 3 quarters · filed 2025-03-03 | $36.83M derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2023-03-31 | $9.37M 10-Q · filed 2024-05-08 | $18.55M derived: sum of 2 quarters · filed 2025-03-03 | $27.41M derived: sum of 3 quarters · filed 2025-03-03 | $36.12M derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2022-12-31 | $9.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $18.05M derived: sum of 2 quarters · filed 2025-03-03 | $26.75M derived: sum of 3 quarters · filed 2025-03-03 | $35.15M 10-K · filed 2025-03-03 | ||
| 2022-09-30 | $8.87M 10-Q · filed 2023-11-08 | $17.57M derived: sum of 2 quarters · filed 2023-11-08 | $25.97M 10-Q · filed 2023-11-08 | $34.26M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-06-30 | $8.70M 10-Q · filed 2023-08-09 | $17.10M 10-Q · filed 2023-08-09 | $25.39M derived: sum of 3 quarters · filed 2024-02-29 | $33.50M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-03-31 | $8.40M 10-Q · filed 2023-05-05 | $16.69M derived: sum of 2 quarters · filed 2024-02-29 | $24.80M derived: sum of 3 quarters · filed 2024-02-29 | $32.70M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2021-12-31 | $8.28M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $16.40M derived: sum of 2 quarters · filed 2024-02-29 | $24.29M derived: sum of 3 quarters · filed 2024-02-29 | $32.02M 10-K · filed 2024-02-29 | ||
| 2021-09-30 | $8.11M 10-Q · filed 2022-11-08 | $16.01M derived: sum of 2 quarters · filed 2022-11-08 | $23.74M 10-Q · filed 2022-11-08 | $31.35M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-06-30 | $7.89M 10-Q · filed 2022-08-08 | $15.62M 10-Q · filed 2022-08-08 | $23.24M derived: sum of 3 quarters · filed 2023-02-28 | $30.71M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-03-31 | $7.73M 10-Q · filed 2022-05-09 | $15.34M derived: sum of 2 quarters · filed 2023-02-28 | $22.81M derived: sum of 3 quarters · filed 2023-02-28 | $30.63M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2020-12-31 | $7.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $15.08M derived: sum of 2 quarters · filed 2023-02-28 | $22.90M derived: sum of 3 quarters · filed 2023-02-28 | $30.71M 10-K · filed 2023-02-28 | ||
| 2020-09-30 | $7.47M 10-Q · filed 2021-11-09 | $15.29M derived: sum of 2 quarters · filed 2021-11-09 | $23.10M 10-Q · filed 2021-11-09 | $38.03M derived: sum of 4 quarters · filed 2021-11-09 | ||
| 2020-06-30 | $7.82M 10-Q · filed 2021-08-09 | $15.63M 10-Q · filed 2021-08-09 | $30.56M derived: sum of 3 quarters · filed 2021-08-09 | $38.27M derived: sum of 4 quarters · filed 2021-08-09 | ||
| 2020-03-31 | $7.81M 10-Q · filed 2021-05-10 | $22.74M derived: sum of 2 quarters · filed 2021-05-10 | $30.45M derived: sum of 3 quarters · filed 2021-05-10 | $38.16M derived: sum of 4 quarters · filed 2021-05-10 | ||
| 2019-12-31 | $14.93M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $22.64M derived: sum of 2 quarters · filed 2021-03-01 | $30.35M derived: sum of 3 quarters · filed 2021-03-01 | $30.23M 10-K · filed 2021-03-01 | ||
| 2019-09-30 | $7.71M 10-Q · filed 2020-11-06 | $7.30M 10-Q · filed 2019-11-08 | $15.42M derived: sum of 2 quarters · filed 2020-11-06 | $15.29M 10-Q · filed 2020-11-06 | $22.60M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $7.71M 10-Q · filed 2020-08-07 | $15.29M 10-Q · filed 2020-08-07 | ||||
| 2019-03-31 | $7.59M 10-Q · filed 2020-05-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |